vs
COMPUGEN LTD（CGEN）与Heritage Distilling Holding Company, Inc.（IPST）财务数据对比。点击上方公司名可切换其他公司
Heritage Distilling Holding Company, Inc.的季度营收约是COMPUGEN LTD的1.3倍（$4.7M vs $3.5M），COMPUGEN LTD净利率更高（-410.1% vs -6862.0%，领先6451.8%）
Compugen是一家处于临床阶段的上市预测药物研发企业，1993年成立，总部位于以色列，最初以计算药物发现服务商身份起家，为制药企业提供软件与计算服务，预测各类生物现象，目前股份同时在纳斯达克资本市场和特拉维夫证券交易所上市交易。
纽波特工艺酿酒蒸馏公司位于美国罗德岛州纽波特，1999年以滨海极限酿酒公司之名成立，是纽波特首家精酿微酿酒厂，2006年新增蒸馏业务，2018年改用现名以体现综合生产定位，目前生产多种啤酒与烈酒产品，分销网络覆盖美国东北部地区。
CGEN vs IPST — 直观对比
营收规模更大
IPST
是对方的1.3倍
$3.5M
净利率更高
CGEN
高出6451.8%
-6862.0%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.5M | $4.7M |
| 净利润 | $-14.5M | $-323.7M |
| 毛利率 | — | 68.5% |
| 营业利润率 | -475.1% | -2622.6% |
| 净利率 | -410.1% | -6862.0% |
| 营收同比 | -61.8% | — |
| 净利润同比 | -54.7% | — |
| 每股收益（稀释后） | $-0.16 | $-31.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CGENIPST
| Q4 25 | — | $4.7M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | $3.5M | $1.3M | ||
| Q1 25 | — | $1.1M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $2.6M | — | ||
| Q2 23 | $0 | — |
净利润CGENIPST
| Q4 25 | — | $-323.7M | ||
| Q3 25 | — | $196.3M | ||
| Q2 25 | $-14.5M | $-7.3M | ||
| Q1 25 | — | $-3.0M | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $7.3M | — | ||
| Q2 23 | $-18.6M | — |
毛利率CGENIPST
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 24.9% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | 60.5% | — | ||
| Q1 24 | 17.9% | — | ||
| Q2 23 | — | — |
营业利润率CGENIPST
| Q4 25 | — | -2622.6% | ||
| Q3 25 | — | -38.4% | ||
| Q2 25 | -475.1% | -503.0% | ||
| Q1 25 | — | -224.5% | ||
| Q3 24 | — | -118.1% | ||
| Q2 24 | -128.5% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
净利率CGENIPST
| Q4 25 | — | -6862.0% | ||
| Q3 25 | — | 6566.2% | ||
| Q2 25 | -410.1% | -551.9% | ||
| Q1 25 | — | -277.8% | ||
| Q3 24 | — | -194.9% | ||
| Q2 24 | -101.4% | — | ||
| Q1 24 | 284.0% | — | ||
| Q2 23 | — | — |
每股收益（稀释后）CGENIPST
| Q4 25 | — | $-31.89 | ||
| Q3 25 | — | $16.97 | ||
| Q2 25 | $-0.16 | $-0.77 | ||
| Q1 25 | — | $-0.34 | ||
| Q3 24 | — | $-160.41 | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $89505618.00 | — | ||
| Q2 23 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.3M | — |
| 总债务越低越好 | — | $2.6M |
| 股东权益账面价值 | $50.3M | $98.2M |
| 总资产 | $106.5M | $108.8M |
| 负债/权益比越低杠杆越低 | — | 0.03× |
8季度趋势，按日历期对齐
现金及短期投资CGENIPST
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $35.3M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $44.6M | — | ||
| Q1 24 | $39.3M | — | ||
| Q2 23 | $21.6M | — |
总债务CGENIPST
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $13.0M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
股东权益CGENIPST
| Q4 25 | — | $98.2M | ||
| Q3 25 | — | $420.4M | ||
| Q2 25 | $50.3M | $-2.9M | ||
| Q1 25 | — | $-329.0K | ||
| Q3 24 | — | $-34.0M | ||
| Q2 24 | $58.3M | — | ||
| Q1 24 | $65.6M | — | ||
| Q2 23 | $62.0M | — |
总资产CGENIPST
| Q4 25 | — | $108.8M | ||
| Q3 25 | — | $482.8M | ||
| Q2 25 | $106.5M | $26.5M | ||
| Q1 25 | — | $27.1M | ||
| Q3 24 | — | $31.1M | ||
| Q2 24 | $110.2M | — | ||
| Q1 24 | $121.3M | — | ||
| Q2 23 | $77.1M | — |
负债/权益比CGENIPST
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.6M | $-7.5M |
| 自由现金流经营现金流 - 资本支出 | $-18.8M | — |
| 自由现金流率自由现金流/营收 | -530.8% | — |
| 资本支出强度资本支出/营收 | 6.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CGENIPST
| Q4 25 | — | $-7.5M | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | $-18.6M | $-1.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | — | — | ||
| Q2 23 | $-18.6M | — |
自由现金流CGENIPST
| Q4 25 | — | — | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | $-18.8M | $-1.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | — | — | ||
| Q2 23 | $-18.6M | — |
自由现金流率CGENIPST
| Q4 25 | — | — | ||
| Q3 25 | — | -144.7% | ||
| Q2 25 | -530.8% | -115.3% | ||
| Q1 25 | — | -187.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | 428.3% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
资本支出强度CGENIPST
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | 6.5% | 0.9% | ||
| Q1 25 | — | 1.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
现金转化率CGENIPST
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CGEN
暂无分部数据
IPST
| Direct To Consumer | $3.0M | 63% |
| Wholesale | $1.2M | 26% |
| Other | $517.7K | 11% |
